Shanghai Soho-Yiming Pharmaceuticals Co., Ltd. (a wholly owned subsidinary by Ankebio) was founded in 2001. It is a high-tech enterprise foucused on research, development, production and sales of different kinds GMP peptides API.

Our company has the first-class facilities of experiment and production, such as automatic peptide synthesis system, separation and purification system, freeze drying system and other instriments. We also independently invent a solid phase technological process which is suitable for industrialized production.

We have been awarded as national high-tech enterprise since 2007. The Somatostain, Octreotide Acetate, Calcitonin(Salmon), Thymalfasin, Thymopentin, Oxytocin and Leuprorelin have won the Shanghai high-tech achievements transformation prize. Our company also pay great importance to the protection of intellectual property. Our company has applied for more than 30 kinds invention patent including Oxytocin, Octreotide Acetate, Somatostain, etc.

Our company had removed to a brand new large-scale GMP peptide production base in Qingpu district, Shanghai. According to cGMP requirements, we have realized strict control to our products quality and passed the FDA on-site inspection with on deficiency in 2017. Till now, our company has 6 GMP products including Somatostain, Thymalfasin, Thymopentin, Calcitonin(Salmon), Octreotide Acetate and Atosiban Acetate. Besides, our Oxytocin and Atosiban Acetate have CEP certificates. We also actively promotely veterinary market, the Gonadorelin and LHRH-A3 also got the animal drugs certificate issued by Shanghai Agriculture and Rural Committe in 2019

Our company is now able to achieve batch production of 6kg, the sales of various kind high purity peptide API could be 300kg every year and our production capacity is about 500kg. Our wish is to make contribution for world peptide pharmaceuticals bussiness in the future.